330 related articles for article (PubMed ID: 28408124)
21. Sources of extracellular tau and its signaling.
Avila J; Simón D; Díaz-Hernández M; Pintor J; Hernández F
J Alzheimers Dis; 2014; 40 Suppl 1():S7-S15. PubMed ID: 24531154
[TBL] [Abstract][Full Text] [Related]
22. The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
Dugger BN; Whiteside CM; Maarouf CL; Walker DG; Beach TG; Sue LI; Garcia A; Dunckley T; Meechoovet B; Reiman EM; Roher AE
J Alzheimers Dis; 2016; 51(2):345-56. PubMed ID: 26890756
[TBL] [Abstract][Full Text] [Related]
23. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP
J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899
[TBL] [Abstract][Full Text] [Related]
24. Long-term overexpression of heme oxygenase 1 promotes tau aggregation in mouse brain by inducing tau phosphorylation.
Hui Y; Wang D; Li W; Zhang L; Jin J; Ma N; Zhou L; Nakajima O; Zhao W; Gao X
J Alzheimers Dis; 2011; 26(2):299-313. PubMed ID: 21613741
[TBL] [Abstract][Full Text] [Related]
25. Fate and propagation of endogenously formed Tau aggregates in neuronal cells.
Chastagner P; Loria F; Vargas JY; Tois J; I Diamond M; Okafo G; Brou C; Zurzolo C
EMBO Mol Med; 2020 Dec; 12(12):e12025. PubMed ID: 33179866
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans.
Weisová P; Cehlár O; Škrabana R; Žilková M; Filipčík P; Kováčech B; Prčina M; Wojčiaková Ľ; Fialová Ľ; Smolek T; Kontseková E; Žilka N; Novák M
Acta Neuropathol Commun; 2019 Aug; 7(1):129. PubMed ID: 31391090
[TBL] [Abstract][Full Text] [Related]
27. DC11: a novel monoclonal antibody revealing Alzheimer's disease-specific tau epitope.
Vechterova L; Kontsekova E; Zilka N; Ferencik M; Ravid R; Novak M
Neuroreport; 2003 Jan; 14(1):87-91. PubMed ID: 12544837
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology.
Maurage CA; Sergeant N; Ruchoux MM; Hauw JJ; Delacourte A
Acta Neuropathol; 2003 Feb; 105(2):89-97. PubMed ID: 12536218
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
Ruan Z; Pathak D; Venkatesan Kalavai S; Yoshii-Kitahara A; Muraoka S; Bhatt N; Takamatsu-Yukawa K; Hu J; Wang Y; Hersh S; Ericsson M; Gorantla S; Gendelman HE; Kayed R; Ikezu S; Luebke JI; Ikezu T
Brain; 2021 Feb; 144(1):288-309. PubMed ID: 33246331
[TBL] [Abstract][Full Text] [Related]
31. Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau.
Courade JP; Angers R; Mairet-Coello G; Pacico N; Tyson K; Lightwood D; Munro R; McMillan D; Griffin R; Baker T; Starkie D; Nan R; Westwood M; Mushikiwabo ML; Jung S; Odede G; Sweeney B; Popplewell A; Burgess G; Downey P; Citron M
Acta Neuropathol; 2018 Nov; 136(5):729-745. PubMed ID: 30238240
[TBL] [Abstract][Full Text] [Related]
32. Distinct Therapeutic Mechanisms of Tau Antibodies: Promoting Microglial Clearance Versus Blocking Neuronal Uptake.
Funk KE; Mirbaha H; Jiang H; Holtzman DM; Diamond MI
J Biol Chem; 2015 Aug; 290(35):21652-62. PubMed ID: 26126828
[TBL] [Abstract][Full Text] [Related]
33. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
[TBL] [Abstract][Full Text] [Related]
34. The release and trans-synaptic transmission of Tau via exosomes.
Wang Y; Balaji V; Kaniyappan S; Krüger L; Irsen S; Tepper K; Chandupatla R; Maetzler W; Schneider A; Mandelkow E; Mandelkow EM
Mol Neurodegener; 2017 Jan; 12(1):5. PubMed ID: 28086931
[TBL] [Abstract][Full Text] [Related]
35. Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics.
Rosseels J; Van den Brande J; Violet M; Jacobs D; Grognet P; Lopez J; Huvent I; Caldara M; Swinnen E; Papegaey A; Caillierez R; Buée-Scherrer V; Engelborghs S; Lippens G; Colin M; Buée L; Galas MC; Vanmechelen E; Winderickx J
J Biol Chem; 2015 Feb; 290(7):4059-74. PubMed ID: 25540200
[TBL] [Abstract][Full Text] [Related]
36. Designing antibodies against LRRK2-targeted tau epitopes.
Hamm M; Ladd TB; Levites Y; Golde TE; Giasson BI; Lewis J
PLoS One; 2018; 13(9):e0204367. PubMed ID: 30261006
[TBL] [Abstract][Full Text] [Related]
37. Characterization of TauC3 antibody and demonstration of its potential to block tau propagation.
Nicholls SB; DeVos SL; Commins C; Nobuhara C; Bennett RE; Corjuc DL; Maury E; Eftekharzadeh B; Akingbade O; Fan Z; Roe AD; Takeda S; Wegmann S; Hyman BT
PLoS One; 2017; 12(5):e0177914. PubMed ID: 28531180
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions.
Togo T; Akiyama H; Iseki E; Uchikado H; Kondo H; Ikeda K; Tsuchiya K; de Silva R; Lees A; Kosaka K
Acta Neuropathol; 2004 Jun; 107(6):504-8. PubMed ID: 15024583
[TBL] [Abstract][Full Text] [Related]
39. Of rodents and men: the mysterious interneuronal pilgrimage of misfolded protein tau in Alzheimer’s disease.
Levarska L; Zilka N; Jadhav S; Neradil P; Novak M
J Alzheimers Dis; 2013; 37(3):569-77. PubMed ID: 23948940
[TBL] [Abstract][Full Text] [Related]
40. Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau.
Strang KH; Goodwin MS; Riffe C; Moore BD; Chakrabarty P; Levites Y; Golde TE; Giasson BI
Acta Neuropathol Commun; 2017 Jul; 5(1):58. PubMed ID: 28760159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]